Consensus-Derived Quality Performance Indicators for Neuroendocrine Tumour Care

Braden  Woodhouse; Sharon  Pattison; Eva Segelov; Simron Singh; Kate Elizabeth Parker; Grace Kong; William  Macdonald; David Wyld; Goswin Meyer-Rochow; Nick Pavlakis; Siobhan  Conroy; Vallerie  Gordon; Jonathan  Koea; Nicole Krämer; Michael Michael; Kate  Wakelin; Tahmina Asif; Dorothy  Lo; Timothy Price; Ben  Lawrence; on behalf of the Commonwealth Neuroendocrine Tumour Collaboration (CommNETs)

Consensus-Derived Quality Performance Indicators for Neuroendocrine Tumour Care

Braden Woodhouse, Sharon Pattison, Eva Segelov, Simron Singh, Kate Elizabeth Parker, Grace Kong, William Macdonald, David Wyld, Goswin Meyer-Rochow, Nick Pavlakis, Siobhan Conroy, Vallerie Gordon, Jonathan Koea, Nicole Krämer, Michael Michael, Kate Wakelin, Tahmina Asif, Dorothy Lo, Timothy Price, Ben Lawrenceon behalf of the Commonwealth Neuroendocrine Tumour Collaboration (CommNETs)

Medicine Monash Health

Research output: Chapter in Book/Report/Conference proceeding › Chapter (Book) › Other › peer-review

Abstract

Quality performance indicators (QPIs) are used to monitor the delivery of cancer care. Neuroendocrine tumours (NETs) are a family of individually uncommon cancers that derive from neuroendocrine cells or their precursors, and can occur in most organs. There are currently no QPIs available for NETs and their heterogeneity makes QPI development difficult. CommNETs is a collaboration between NET clinicians, researchers and advocates in Canada, Australia and New Zealand. We created QPIs for NETs using a three-step consensus process. First, a multidisciplinary team used the nominal group technique to create candidates (n = 133) which were then curated into appropriateness statements (62 statements, 44 sub-statements). A two-stage modified RAND/UCLA Delphi consensus process was conducted: an online survey rated the statement appropriateness then the top-ranked statements (n = 20) were assessed in a face-to-face meeting. Finally, 10 QPIs met consensus criteria; documentation of primary site, proliferative index, differentiation, tumour board review, use of a structured pathology report, presence of distant metastasis, 5- and 10-year disease-free and overall survival. These NET QPIs will be trialed as a method to monitor and improve care for people with NETs and to facilitate international comparison.

Original language	English
Title of host publication	Advances in Diagnosis and Therapy of Neuroendocrine Neoplasms
Editors	Eva Segelov
Place of Publication	Switzerland
Publisher	MDPI AG
Pages	15-26
Number of pages	12
ISBN (Print)	9783039437450, 9783039437467
Publication status	Published - Jan 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

1 Article

Consensus-Derived Quality Performance Indicators for Neuroendocrine Tumour Care
Woodhouse, B., Pattison, S., Segelov, E., Singh, S., Parker, K. E., Kong, G., Macdonald, W., Wyld, D., Meyer-Rochow, G., Pavlakis, N., Conroy, S., Gordon, V., Koea, J., Krämer, N., Michael, M., Wakelin, K., Asif, T., Lo, D., Price, T., Lawrence, B., & 1 otherson behalf of the Commonwealth Neuroendocrine Tumour Collaboration (CommNETs) , Sept 2019, In: Journal of Clinical Medicine. 8, 9, 13 p., 1455.
Research output: Contribution to journal › Article › Research › peer-review

Open Access
File

Cite this

Woodhouse, B., Pattison, S., Segelov, E., Singh, S., Parker, K. E., Kong, G., Macdonald, W., Wyld, D., Meyer-Rochow, G., Pavlakis, N., Conroy, S., Gordon, V., Koea, J., Krämer, N., Michael, M., Wakelin, K., Asif, T., Lo, D., Price, T., ... on behalf of the Commonwealth Neuroendocrine Tumour Collaboration (CommNETs) (2021). Consensus-Derived Quality Performance Indicators for Neuroendocrine Tumour Care. In E. Segelov (Ed.), Advances in Diagnosis and Therapy of Neuroendocrine Neoplasms (pp. 15-26). MDPI AG.

@inbook{6275cd43de0748f7bdb979fe3c51cee3,

title = "Consensus-Derived Quality Performance Indicators for Neuroendocrine Tumour Care",

abstract = "Quality performance indicators (QPIs) are used to monitor the delivery of cancer care. Neuroendocrine tumours (NETs) are a family of individually uncommon cancers that derive from neuroendocrine cells or their precursors, and can occur in most organs. There are currently no QPIs available for NETs and their heterogeneity makes QPI development difficult. CommNETs is a collaboration between NET clinicians, researchers and advocates in Canada, Australia and New Zealand. We created QPIs for NETs using a three-step consensus process. First, a multidisciplinary team used the nominal group technique to create candidates (n = 133) which were then curated into appropriateness statements (62 statements, 44 sub-statements). A two-stage modified RAND/UCLA Delphi consensus process was conducted: an online survey rated the statement appropriateness then the top-ranked statements (n = 20) were assessed in a face-to-face meeting. Finally, 10 QPIs met consensus criteria; documentation of primary site, proliferative index, differentiation, tumour board review, use of a structured pathology report, presence of distant metastasis, 5- and 10-year disease-free and overall survival. These NET QPIs will be trialed as a method to monitor and improve care for people with NETs and to facilitate international comparison.",

author = "Braden Woodhouse and Sharon Pattison and Eva Segelov and Simron Singh and Parker, {Kate Elizabeth} and Grace Kong and William Macdonald and David Wyld and Goswin Meyer-Rochow and Nick Pavlakis and Siobhan Conroy and Vallerie Gordon and Jonathan Koea and Nicole Kr{\"a}mer and Michael Michael and Kate Wakelin and Tahmina Asif and Dorothy Lo and Timothy Price and Ben Lawrence and {on behalf of the Commonwealth Neuroendocrine Tumour Collaboration (CommNETs)}",

year = "2021",

month = jan,

language = "English",

isbn = "9783039437450",

pages = "15--26",

editor = "Eva Segelov",

booktitle = "Advances in Diagnosis and Therapy of Neuroendocrine Neoplasms",

publisher = "MDPI AG",

address = "Switzerland",

}

Woodhouse, B, Pattison, S, Segelov, E, Singh, S, Parker, KE, Kong, G, Macdonald, W, Wyld, D, Meyer-Rochow, G, Pavlakis, N, Conroy, S, Gordon, V, Koea, J, Krämer, N, Michael, M, Wakelin, K, Asif, T, Lo, D, Price, T, Lawrence, B & on behalf of the Commonwealth Neuroendocrine Tumour Collaboration (CommNETs) 2021, Consensus-Derived Quality Performance Indicators for Neuroendocrine Tumour Care. in E Segelov (ed.), Advances in Diagnosis and Therapy of Neuroendocrine Neoplasms. MDPI AG, Switzerland, pp. 15-26.

TY - CHAP

T1 - Consensus-Derived Quality Performance Indicators for Neuroendocrine Tumour Care

AU - Woodhouse, Braden

AU - Pattison, Sharon

AU - Segelov, Eva

AU - Singh, Simron

AU - Parker, Kate Elizabeth

AU - Kong, Grace

AU - Macdonald, William

AU - Wyld, David

AU - Meyer-Rochow, Goswin

AU - Pavlakis, Nick

AU - Conroy, Siobhan

AU - Gordon, Vallerie

AU - Koea, Jonathan

AU - Krämer, Nicole

AU - Michael, Michael

AU - Wakelin, Kate

AU - Asif, Tahmina

AU - Lo, Dorothy

AU - Price, Timothy

AU - Lawrence, Ben

AU - on behalf of the Commonwealth Neuroendocrine Tumour Collaboration (CommNETs)

PY - 2021/1

Y1 - 2021/1

N2 - Quality performance indicators (QPIs) are used to monitor the delivery of cancer care. Neuroendocrine tumours (NETs) are a family of individually uncommon cancers that derive from neuroendocrine cells or their precursors, and can occur in most organs. There are currently no QPIs available for NETs and their heterogeneity makes QPI development difficult. CommNETs is a collaboration between NET clinicians, researchers and advocates in Canada, Australia and New Zealand. We created QPIs for NETs using a three-step consensus process. First, a multidisciplinary team used the nominal group technique to create candidates (n = 133) which were then curated into appropriateness statements (62 statements, 44 sub-statements). A two-stage modified RAND/UCLA Delphi consensus process was conducted: an online survey rated the statement appropriateness then the top-ranked statements (n = 20) were assessed in a face-to-face meeting. Finally, 10 QPIs met consensus criteria; documentation of primary site, proliferative index, differentiation, tumour board review, use of a structured pathology report, presence of distant metastasis, 5- and 10-year disease-free and overall survival. These NET QPIs will be trialed as a method to monitor and improve care for people with NETs and to facilitate international comparison.

AB - Quality performance indicators (QPIs) are used to monitor the delivery of cancer care. Neuroendocrine tumours (NETs) are a family of individually uncommon cancers that derive from neuroendocrine cells or their precursors, and can occur in most organs. There are currently no QPIs available for NETs and their heterogeneity makes QPI development difficult. CommNETs is a collaboration between NET clinicians, researchers and advocates in Canada, Australia and New Zealand. We created QPIs for NETs using a three-step consensus process. First, a multidisciplinary team used the nominal group technique to create candidates (n = 133) which were then curated into appropriateness statements (62 statements, 44 sub-statements). A two-stage modified RAND/UCLA Delphi consensus process was conducted: an online survey rated the statement appropriateness then the top-ranked statements (n = 20) were assessed in a face-to-face meeting. Finally, 10 QPIs met consensus criteria; documentation of primary site, proliferative index, differentiation, tumour board review, use of a structured pathology report, presence of distant metastasis, 5- and 10-year disease-free and overall survival. These NET QPIs will be trialed as a method to monitor and improve care for people with NETs and to facilitate international comparison.

M3 - Chapter (Book)

SN - 9783039437450

SN - 9783039437467

SP - 15

EP - 26

BT - Advances in Diagnosis and Therapy of Neuroendocrine Neoplasms

A2 - Segelov, Eva

PB - MDPI AG

CY - Switzerland

ER -